Skip to main content

Table 1 Clinical characteristics of study population (n = 272)

From: Polypharmacy and adverse outcomes after hip fracture surgery

Parameter

Mean/proportion

Std. deviation

Minimum

Maximum

Age, years

82.0

9.0

53

100

Gender, n, % females

196

72.1

   

P-Glucose admission, mmol/L

7.5

2.1

3.4

19.8

P-Glucose, 3rd day, mmol/L

9.0

3.2

5.7

16.9

P-Sodium admission, mmol/L

138.7

3.4

125.0

147.0

P-Sodium 3rd day, mmol/L

137.0

3.5

120.0

146.0

P-Potassium admission, mmol/L

3.9

0.5

2.6

5.9

P-Potassium 3rd day, mmol/L

3.7

0.5

2.4

5.5

P-Creatinine admission, μmol/L

88.5

48.6

26.0

563.0

P-Creatinine 3rd day, μmol/L

91.2

67.4

34.0

614.0

P-Hemoglobin admission, g/L

122.7

15.7

74.0

192.0

P-Hemoglobin 3rd day, g/L

106.2

13.1

72.0

143.0

Blood pressure-systolic admission, mmHg

144

22

90

220

Blood pressure-systolic 3rd day, mmHg

121

18

70

180

Blood pressure-diastolic admission, mmHg

75

12

50

120

Blood pressure-diastolic 3rd day, mmHg

63

10

40

100

No. of medications, admission

6.2

3.9

0.0

20.0

No. of medications, discharge

7.8

3.6

0.0

20.0

  1. Glucose, sodium, potassium, and creatinine were plasma levels